Why is CVS Health (CVS) stock up today?

CVS Health shares climbed 0.83% to $106.81 on July 14, 2026, driven by a concentrated wave of analyst upgrades and price-target raises from major Wall Street firms. Wells Fargo, Mizuho, Leerink Partners, Goldman Sachs, and Truist all raised their price targets on CVS within roughly 24 hours — setting new targets ranging from $116 to $123 — while each maintained a bullish rating (Overweight, Outperform, or Buy). When multiple respected analysts increase their price targets above the current share price simultaneously, it signals growing institutional confidence and often draws fresh buying from funds that use analyst consensus as a guide.

The analyst activity appears tied in part to CVS's strong last-quarter results: the company reported earnings per share of $2.57 against an estimate of roughly $2.21, a meaningful beat, with revenue of $100.43 billion. The company's forward price-to-earnings ratio (P/E, a measure of how expensive a stock is relative to expected profits) stands at 12.6, well below the trailing P/E of 45.6, suggesting analysts see substantial near-term earnings improvement ahead. Earnings growth of 63.1% year-over-year further underpins the bullish case reflected in the raised targets.

The broader market provided a modestly supportive backdrop: the S&P 500 gained 0.16% and the Nasdaq 100 added 0.94% after a surprise Consumer Price Index (CPI) inflation report came in below expectations. Lower-than-forecast inflation can ease concerns about interest rates remaining high, which generally benefits a wide range of stocks. CVS's gain modestly outpaced the broader market, pointing to company-specific drivers rather than a simple macro lift.

Sector peers Humana and UnitedHealth were also in the news around Medicare Advantage margins, a segment relevant to CVS's insurance and pharmacy-benefits operations. CVS is scheduled to report its next quarterly earnings on August 5, 2026, which will be the next major company-specific event for investors to watch. As of now, the stock sits at the top of today's intraday range of $106.49 to $106.81, reflecting sustained buying interest through the session.